1. (a) A pharmaceutical drug take-back collection event established by any government or private entity, pursuant to RSA 318-E shall be voluntary.
2. (b) If a government or private entity establishes a pharmaceutical drug take back collection event, it shall be done in accordance with these rules and in conjunction with a participating chief law enforcement officer of a law enforcement agency.

3. (c) The chief law enforcement officer of the law enforcement agency seeking to establish a collection event in conjunction with a government entity or private entity, shall first request and obtain written authorization, pursuant to 21 C.F.R. § 1317, from the:

   Drug Enforcement Administration – Office of Diversion Control

   NEW ENGLAND DIVISION

   JFK Federal Building

   15 New Sudbury Street, Room E-400

   Boston, MA 02203

4. (617) 557-2191

5. (d) The chief law enforcement officer of a law enforcement agency establishing a pharmaceutical drug take-back collection event in conjunction with a government entity or private entity, shall provide written notification to the attorney general that the agency has established an event in accordance with these rules. Written notification shall be sent to:

   Department of Justice

   Criminal Bureau

   33 Capitol Street

   Concord, NH 03301

Source. #10177, eff 8-23-12; ss by #13551, eff 2-2-23